{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:12:21Z","timestamp":1789769541577,"version":"4.0.1"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomed Microdevices"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10544-025-00773-y","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:38:14Z","timestamp":1760949494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Engineering vascularized brain tumor organoids: bridging the gap between models and reality"],"prefix":"10.1007","volume":"27","author":[{"given":"Amirali","family":"Hariri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Zarepour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Iravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"1","key":"773_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41420-023-01523-w","volume":"9","author":"YK Adlakha","year":"2023","unstructured":"Y.K. Adlakha, Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. Cell Death Discovery 9(1), 221 (2023)","journal-title":"Cell Death Discovery"},{"issue":"03","key":"773_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cpt.2023.01.002","volume":"1","author":"T Ahmed","year":"2023","unstructured":"T. Ahmed, Biomaterial-based in vitro 3D modeling of glioblastoma multiforme. Cancer Pathogenesis Therapy. 1(03), 177\u2013194 (2023)","journal-title":"Cancer Pathogenesis Therapy"},{"key":"773_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18560","volume":"28","author":"Y Aili","year":"2024","unstructured":"Y. Aili, N. Maimaitiming, Z. Wang, Y. Wang, Brain organoids: a new tool for modelling of neurodevelopmental disorders. J. Cell. Mol. Med. 28, e18560 (2024)","journal-title":"J. Cell. Mol. Med."},{"key":"773_CR4","doi-asserted-by":"crossref","unstructured":"F. Antonica, G. Aiello, A. Soldano, L. Abballe, E. Miele, L. Tiberi, Modeling brain tumors: A perspective overview of in vivo and organoid models. Front. Mol. Neurosci. 15, 818696\u00a0(2022a)","DOI":"10.3389\/fnmol.2022.818696"},{"key":"773_CR5","doi-asserted-by":"crossref","unstructured":"F. Antonica, L. Santomaso, D. Pernici, L. Petrucci, G. Aiello, A. Cutarelli et al., A slow-cycling\/quiescent cells subpopulation is involved in glioma invasiveness. Nat. Commun. 13(1)(2022b)","DOI":"10.1038\/s41467-022-32448-0"},{"issue":"6","key":"773_CR6","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2014.9.FOCUS14521","volume":"37","author":"DJ Aum","year":"2014","unstructured":"D.J. Aum, D.H. Kim, T.L. Beaumont, E.C. Leuthardt, G.P. Dunn, A.H. Kim, Molecular and cellular heterogeneity: the hallmark of glioblastoma. Neurosurg. Focus 37, E11 (2014).","journal-title":"Neurosurg. Focus"},{"key":"773_CR7","doi-asserted-by":"crossref","unstructured":"R. Azzarelli, M. Ori, A. Philpott, B.D. Simons, Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids. Biology Open. 10(2),\u00a0bio056416 (2021)","DOI":"10.1242\/bio.056416"},{"issue":"1","key":"773_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-00183-7","volume":"17","author":"A Bhalerao","year":"2020","unstructured":"A. Bhalerao, F. Sivandzade, S.R. Archie, E.A. Chowdhury, B. Noorani, L. Cucullo, In vitro modeling of the neurovascular unit: advances in the field. Fluids Barriers CNS. 17(1), 22 (2020)","journal-title":"Fluids Barriers CNS."},{"issue":"8","key":"773_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","volume":"15","author":"S Bian","year":"2018","unstructured":"S. Bian, M. Repic, Z. Guo, A. Kavirayani, T. Burkard, J.A. Bagley et al., Genetically engineered cerebral organoids model brain tumor formation. Nat. Methods. 15(8), 631\u2013639 (2018)","journal-title":"Nat. Methods"},{"issue":"12","key":"773_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115068","volume":"43","author":"SM Boutom","year":"2024","unstructured":"S.M. Boutom, T.P. Silva, S.P. Palecek, E.V. Shusta, T.G. Fernandes, R.S. Ashton, Central nervous system vascularization in human embryos and neural organoids. Cell Rep. 43(12), 115068 (2024)","journal-title":"Cell Rep."},{"issue":"14","key":"773_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141856","volume":"12","author":"FK Braun","year":"2023","unstructured":"F.K. Braun, T. Rothhammer-Hampl, J. Lorenz, S. Pohl, A.-N. Menevse, A. Vollmann-Zwerenz et al., Scaffold-based (Matrigel\u2122) 3D culture technique of glioblastoma recovers a patient-like immunosuppressive phenotype. Cells.\u00a012(14), 1856 (2023)","journal-title":"Cells"},{"key":"773_CR12","doi-asserted-by":"crossref","unstructured":"L.L. Berube, P. Kwang-ok, M. Iida, S. Ramisetty, P. Kulkarni, R. Salgia et al., (eds.), Radiation Sensitivity: the Rise of Predictive Patient-Derived Cancer Models. Seminars in Radiation Oncology. Elsevier (2023)","DOI":"10.1016\/j.semradonc.2023.03.005"},{"issue":"11\u201312","key":"773_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/ten.tea.2023.0209","volume":"30","author":"M Cabral","year":"2024","unstructured":"M. Cabral, K. Cheng, D. Zhu, Three-dimensional bioprinting of organoids: past, present, and prospective. Tissue Eng. Part A 30(11\u201312), 314\u2013321 (2024)","journal-title":"Tissue Eng. Part A"},{"issue":"2","key":"773_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1021\/acsabm.1c01138","volume":"5","author":"IR Calori","year":"2022","unstructured":"I.R. Calori, S.R. Alves, H. Bi, A.C. Tedesco, Type-I collagen\/collagenase modulates the 3d structure and behavior of glioblastoma spheroid models. ACS Appl. Bio Mater. 5(2), 723\u2013733 (2022)","journal-title":"ACS Appl. Bio Mater."},{"key":"773_CR15","doi-asserted-by":"crossref","unstructured":"M. Chadwick, C. Yang, L. Liu, C.M. Gamboa, K. Jara, H. Lee et al., Rapid processing and drug evaluation in glioblastoma patient-derived organoid models with 4D bioprinted arrays. Iscience. 23(8), 101365 (2020)","DOI":"10.1016\/j.isci.2020.101365"},{"issue":"11","key":"773_CR16","doi-asserted-by":"publisher","first-page":"20085","DOI":"10.1002\/jcp.28608","volume":"234","author":"N Chaicharoenaudomrung","year":"2019","unstructured":"N. Chaicharoenaudomrung, P. Kunhorm, W. Promjantuek, N. Heebkaew, N. Rujanapun, P. Noisa, Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation. J. Cell. Physiol. 234(11), 20085\u201320097 (2019)","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"773_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20487-y","volume":"12","author":"C-C Chen","year":"2022","unstructured":"C.-C. Chen, H.-W. Li, Y.-L. Wang, C.-C. Lee, Y.-C. Shen, C.-Y. Hsieh et al., Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors. Sci. Rep. 12(1), 16399 (2022)","journal-title":"Sci. Rep."},{"issue":"13","key":"773_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102784","volume":"11","author":"H Chen","year":"2022","unstructured":"H. Chen, Z. Wu, Z. Gong, Y. Xia, J. Li, L. Du et al., Acoustic bioprinting of patient-derived organoids for predicting cancer therapy responses. Adv. Healthc. Mater. 11(13), 2102784 (2022)","journal-title":"Adv. Healthc. Mater."},{"key":"773_CR19","doi-asserted-by":"crossref","unstructured":"C. Chesnelong, I. Restall, S. Weiss, Isolation and culture of glioblastoma brain tumor stem cells. In:Brain Tumor Stem Cells: Methods Protoc. (Springer, New York, 2019), p. 11\u201321","DOI":"10.1007\/978-1-4939-8805-1_2"},{"issue":"1","key":"773_CR20","doi-asserted-by":"publisher","first-page":"015014","DOI":"10.1088\/1748-605X\/aca05d","volume":"18","author":"CC Clark","year":"2022","unstructured":"C.C. Clark, K.M. Yoo, H. Sivakumar, K. Strumpf, A.W. Laxton, S.B. Tatter et al., Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids. Biomed. Mater. 18(1), 015014 (2022)","journal-title":"Biomed. Mater."},{"issue":"4","key":"773_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/cells14040292","volume":"14","author":"CD Correia","year":"2025","unstructured":"C.D. Correia, S.M. Calado, A. Matos, F. Esteves, A.L. De Sousa-Coelho, M.A. Campinho et al., Advancing glioblastoma research with innovative brain organoid-based models. Cells 14(4), 292 (2025)","journal-title":"Cells"},{"issue":"3","key":"773_CR22","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acsbiomaterials.9b00161","volume":"5","author":"MC Cox","year":"2019","unstructured":"M.C. Cox, C. Deng, L.B. Naler, C. Lu, S.S. Verbridge, Effects of culture condition on epigenomic profiles of brain tumor cells. ACS Biomater. Sci. Eng. 5(3), 1544\u20131552 (2019)","journal-title":"ACS Biomater. Sci. Eng."},{"key":"773_CR23","doi-asserted-by":"publisher","first-page":"e52253","DOI":"10.7554\/eLife.52253","volume":"9","author":"X Cui","year":"2020","unstructured":"X. Cui, C. Ma, V. Vasudevaraja, J. Serrano, J. Tong, Y. Peng et al., Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife. 9, e52253 (2020)","journal-title":"Elife"},{"key":"773_CR24","doi-asserted-by":"crossref","unstructured":"A. Delaidelli, A. Moiraghi, Recent advances in the diagnosis and treatment of brain tumors. Brain Sci. 14(3), 224 (2024)","DOI":"10.3390\/brainsci14030224"},{"key":"773_CR25","doi-asserted-by":"publisher","first-page":"778193","DOI":"10.3389\/fphar.2022.778193","volume":"13","author":"M dePadua","year":"2022","unstructured":"M. dePadua, P. Kulothungan, R. Lath, R. Prasad, K. Madamchetty, S. Atmakuri et al., Establishment and characterization of brain cancer primary cell cultures from patients to enable phenotypic screening for new drugs. Front. Pharmacol. 13, 778193 (2022)","journal-title":"Front. Pharmacol."},{"key":"773_CR26","doi-asserted-by":"publisher","first-page":"114067","DOI":"10.1016\/j.addr.2021.114067","volume":"180","author":"T DePalma","year":"2021","unstructured":"T. DePalma, H. Sivakumar, A. Skardal, Strategies for developing complex Multi-Component in vitro tumor models: highlights in glioblastoma. Adv. Drug Deliv Rev. 180, 114067 (2021)","journal-title":"Adv. Drug Deliv Rev."},{"key":"773_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bios.2014.09.049","volume":"67","author":"M Eichler","year":"2015","unstructured":"M. Eichler, H.-G. Jahnke, D. Krinke, A. M\u00fcller, S. Schmidt, R. Azendorf et al., A novel 96-well multielectrode array based impedimetric monitoring platform for comparative drug efficacy analysis on 2D and 3D brain tumor cultures. Biosens. Bioelectron. 67, 582\u2013589 (2015)","journal-title":"Biosens. Bioelectron."},{"key":"773_CR28","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41388-023-02738-y","volume":"42","author":"D Eisenbarth","year":"2023","unstructured":"D. Eisenbarth, Y.A. Wang, Glioblastoma heterogeneity at single cell resolution. Oncogene. 42, 2155\u20132165 (2023)","journal-title":"Oncogene"},{"issue":"4","key":"773_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/organoids2040013","volume":"2","author":"RC Estridge","year":"2023","unstructured":"R.C. Estridge, J.E. O\u2019Neill, A.J. Keung, Matrigel tunes H9 stem cell-derived human cerebral organoid development. Organoids 2(4), 165\u2013176 (2023)","journal-title":"Organoids"},{"issue":"8","key":"773_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/cells12081181","volume":"12","author":"R Fabbri","year":"2023","unstructured":"R. Fabbri, L. Cacopardo, A. Ahluwalia, C. Magliaro, Advanced 3D models of human brain tissue using neural cell lines: state-of-the-art and future prospects. Cells. 12(8), 1181 (2023)","journal-title":"Cells"},{"key":"773_CR31","doi-asserted-by":"publisher","first-page":"110264","DOI":"10.1016\/j.msec.2019.110264","volume":"107","author":"JC Fontoura","year":"2020","unstructured":"J.C. Fontoura, C. Viezzer, dos F.G. Santos, R.A. Ligabue, R. Weinlich, R.D. Puga et al., Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. Mater. Sci. Engineering: C 107, 110264 (2020)","journal-title":"Mater. Sci. Engineering: C"},{"issue":"6216","key":"773_CR32","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"K. Funato, T. Major, P.W. Lewis, C.D. Allis, V. Tabar, Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science. 346(6216), 1529\u20131533 (2014)","journal-title":"Science"},{"issue":"19","key":"773_CR33","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1182\/bloodadvances.2023011145","volume":"8","author":"P Gebing","year":"2024","unstructured":"P. Gebing, S. Loizou, S. H\u00e4nsch, J. Schliehe-Diecks, L. Spory, P. Stachura et al., A brain organoid\/all coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL. Blood Adv. 8(19), 4997\u20135011 (2024)","journal-title":"Blood Adv."},{"issue":"6","key":"773_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","volume":"140","author":"A Golebiewska","year":"2020","unstructured":"A. Golebiewska, A.C. Hau, A. Oudin, D. Stieber, Y.A. Yabo, V. Baus et al., Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathol. 140(6), 919\u2013949 (2020)","journal-title":"Acta Neuropathol."},{"issue":"2","key":"773_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/1535-7163.MCT-18-1320","volume":"19","author":"N Gomez-Roman","year":"2020","unstructured":"N. Gomez-Roman, M.Y. Chong, S.K. Chahal, S.P. Caragher, M.R. Jackson, K.H. Stevenson et al., Radiation responses of 2D and 3D glioblastoma cells: a novel, 3D-specific radioprotective role of vegf\/akt signaling through functional activation of NHEJ. Mol. Cancer Ther. 19(2), 575\u2013589 (2020)","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"773_CR36","first-page":"229","volume":"19","author":"N Gomez-Roman","year":"2017","unstructured":"N. Gomez-Roman, K. Stevenson, L. Gilmour, G. Hamilton, A.J. Chalmers, A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses. Neuro-oncol. 19(2), 229\u2013241 (2017)","journal-title":"Neuro-oncol."},{"key":"773_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114777","volume":"196","author":"E Gonzales-Aloy","year":"2023","unstructured":"E. Gonzales-Aloy, A. Ahmed-Cox, M. Tsoli, D.S. Ziegler, M. Kavallaris, From cells to organoids: the evolution of blood-brain barrier technology for modelling drug delivery in brain cancer. Adv. Drug Deliv. Rev. 196, 114777 (2023)","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"773_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107738","volume":"31","author":"G Goranci-Buzhala","year":"2020","unstructured":"G. Goranci-Buzhala, A. Mariappan, E. Gabriel, A. Ramani, L. Ricci-Vitiani, M. Buccarelli et al., Rapid and efficient invasion assay of glioblastoma in human brain organoids. Cell Rep. 31(10), 107738 (2020)","journal-title":"Cell Rep."},{"issue":"8","key":"773_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082993","volume":"21","author":"S Han","year":"2020","unstructured":"S. Han, S. Kim, Z. Chen, H.K. Shin, S.-Y. Lee, H.E. Moon et al., 3D bioprinted vascularized tumour for drug testing. Int. J. Mol. Sci. 21(8), 2993 (2020)","journal-title":"Int. J. Mol. Sci."},{"key":"773_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"E. Henke, R. Nandigama, S. Erg\u00fcn, Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front. Mol. Biosci. 6, 160 (2019)","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"773_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s44222-024-00268-0","volume":"3","author":"MS Huang","year":"2025","unstructured":"M.S. Huang, F. Christakopoulos, J.G. Roth, S.C. Heilshorn, Organoid bioprinting: from cells to functional tissues. Nat. Reviews Bioeng. 3(2), 126\u2013142 (2025)","journal-title":"Nat. Reviews Bioeng."},{"issue":"8","key":"773_CR42","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","volume":"76","author":"CG Hubert","year":"2016","unstructured":"C.G. Hubert, M. Rivera, L.C. Spangler, Q. Wu, S.C. Mack, B.C. Prager et al., A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 76(8), 2465\u20132477 (2016)","journal-title":"Cancer Res."},{"issue":"4","key":"773_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129540","volume":"1864","author":"JW Hwang","year":"2020","unstructured":"J.W. Hwang, J. Loisel-Duwattez, C. Desterke, T. Latsis, S. Pagliaro, F. Griscelli et al., A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC). Biochim. Biophys. Acta Gen. Subj. 1864(4), 129540 (2020)","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"7","key":"773_CR44","doi-asserted-by":"publisher","first-page":"e18222","DOI":"10.1016\/j.heliyon.2023.e18222","volume":"9","author":"I Ilic","year":"2023","unstructured":"I. Ilic, M. Ilic, International patterns and trends in the brain cancer incidence and mortality: an observational study based on the global burden of disease. Heliyon. 9(7), e18222 (2023)","journal-title":"Heliyon"},{"issue":"2","key":"773_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3892\/or.2015.4021","volume":"34","author":"C-N Im","year":"2015","unstructured":"C.-N. Im, H.H. Yun, H.J. Yoo, M.-J. Park, J.-H. Lee, Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions. Oncol. Rep. 34(2), 920\u2013928 (2015)","journal-title":"Oncol. Rep."},{"issue":"10","key":"773_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410110","volume":"12","author":"M Ishahak","year":"2025","unstructured":"M. Ishahak, R.H. Han, D. Annamalai, T. Woodiwiss, C. McCornack, R.T. Cleary et al., Genetically engineered brain organoids recapitulate spatial and developmental states of glioblastoma progression. Adv. Sci. 12(10), 2410110 (2025)","journal-title":"Adv. Sci."},{"issue":"1","key":"773_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"F. Jacob, R.D. Salinas, D.Y. Zhang, P.T. Nguyen, J.G. Schnoll, S.Z.H. Wong et al., A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity. Cell. 180(1), 188\u2013204 (2020). e22","journal-title":"Cell"},{"issue":"12","key":"773_CR48","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","volume":"15","author":"F Jacob","year":"2020","unstructured":"F. Jacob, G.- Ming, H. Song, Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nat. Protoc. 15(12), 4000\u20134033 (2020)","journal-title":"Nat. Protoc."},{"key":"773_CR49","doi-asserted-by":"publisher","first-page":"1232528","DOI":"10.3389\/fcell.2023.1232528","volume":"11","author":"X Jiang","year":"2023","unstructured":"X. Jiang, L. Oyang, Q. Peng, Q. Liu, X. Xu, N. Wu et al., Organoids: opportunities and challenges of cancer therapy. Front. Cell Dev. Biol. 11, 1232528 (2023)","journal-title":"Front. Cell Dev. Biol."},{"key":"773_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coph.2021.08.019","volume":"61","author":"JV Joseph","year":"2021","unstructured":"J.V. Joseph, M.S. Blaavand, T. Daubon, F.A. Kruyt, M.K. Thomsen, Three-dimensional culture models to study glioblastoma - current trends and future perspectives. Curr. Opin. Pharmacol. 61, 91\u201397 (2021)","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"773_CR51","first-page":"910","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"M. Kapa\u0142czy\u0144ska, T. Kolenda, W. Przyby\u0142a, M. Zaj\u0105czkowska, A. Teresiak, V. Filas et al., 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch. Med. Sci. 14(4), 910\u2013919 (2018)","journal-title":"Arch. Med. Sci."},{"key":"773_CR52","doi-asserted-by":"crossref","unstructured":"Z.I. Khamis, D.B. Sarker, Y. Xue, N. Al-Akkary, V.D. James, C. Zeng et al., Modeling human brain tumors and the microenvironment using induced pluripotent stem cells. Cancers (Basel). 15(4), 1253 (2023)","DOI":"10.3390\/cancers15041253"},{"key":"773_CR53","doi-asserted-by":"crossref","unstructured":"L. Kistemaker, E.J. van Bodegraven, H.E. de Vries, E.M. Hol, Vascularized human brain organoids: current possibilities and prospects. Trends Biotechnol. 43(6), 1275\u20131285 (2025)","DOI":"10.1016\/j.tibtech.2024.11.021"},{"key":"773_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1048731","volume":"10","author":"E LaMontagne","year":"2022","unstructured":"E. LaMontagne, A.R. Muotri, A.J. Engler, Recent advancements and future requirements in vascularization of cortical organoids. Front. Bioeng. Biotechnol. 10, 1048731 (2022)","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"773_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccell.2022.02.016","volume":"40","author":"VG LeBlanc","year":"2022","unstructured":"V.G. LeBlanc, D.L. Trinh, S. Aslanpour, M. Hughes, D. Livingstone, D. Jin et al., Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter-and intratumor heterogeneity. Cancer Cell. 40(4), 379\u2013392 (2022)","journal-title":"Cancer Cell."},{"key":"773_CR56","doi-asserted-by":"crossref","unstructured":"S. Lenin, E. Ponthier, K.G. Scheer, E.C.F. Yeo, M.N. Tea, L.M. Ebert et al., A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma. Int. J. Mol. Sci. 22(9), 4322(2021)","DOI":"10.3390\/ijms22094322"},{"issue":"1","key":"773_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01346-w","volume":"15","author":"J Liang","year":"2024","unstructured":"J. Liang, P. He, A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective. Discov. Oncol. 15(1), 459 (2024)","journal-title":"Discov. Oncol."},{"issue":"4","key":"773_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/mco2.341","volume":"4","author":"S Lin","year":"2023","unstructured":"S. Lin, K. Li, L. Qi, Cancer stem cells in brain tumors: From origin to clinical implications. MedComm (2020) 4(4), 341 (2023)","journal-title":"MedComm (2020)"},{"issue":"12","key":"773_CR59","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","volume":"26","author":"A Linkous","year":"2019","unstructured":"A. Linkous, D. Balamatsias, M. Snuderl, L. Edwards, K. Miyaguchi, T. Milner et al., Modeling patient-derived glioblastoma with cerebral organoids. Cell. Rep. 26(12), 3203\u20133211 (2019). e5","journal-title":"Cell. Rep."},{"key":"773_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117942","volume":"185","author":"X Liu","year":"2025","unstructured":"X. Liu, Z. Zhou, Y. Zhang, H. Zhong, X. Cai, R. Guan, Recent progress on the organoids: techniques, advantages and applications. Biomed. Pharmacother. 185, 117942 (2025)","journal-title":"Biomed. Pharmacother."},{"key":"773_CR61","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.7150\/thno.91362","volume":"14","author":"J Lv","year":"2024","unstructured":"J. Lv, X. Du, M. Wang, J. Su, Y. Wei, C. Xu, Construction of tumor organoids and their application to cancer research and therapy. Theranostics 14, 1101\u20131125 (2024)","journal-title":"Theranostics"},{"key":"773_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48347-2","volume":"9","author":"C Magliaro","year":"2019","unstructured":"C. Magliaro, A. Rinaldo, A. Ahluwalia, Allometric scaling of physiologically-relevant organoids. Sci. Rep. 9, 11890 (2019)","journal-title":"Sci. Rep."},{"key":"773_CR63","doi-asserted-by":"publisher","first-page":"621970","DOI":"10.3389\/fphys.2021.621970","volume":"12","author":"EA Makrygianni","year":"2021","unstructured":"E.A. Makrygianni, G.P. Chrousos, From brain organoids to networking assembloids: implications for neuroendocrinology and stress medicine. Front. Physiol. 12, 621970 (2021)","journal-title":"Front. Physiol."},{"issue":"8","key":"773_CR64","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/bit.28481","volume":"120","author":"C Manikandan","year":"2023","unstructured":"C. Manikandan, A.K. Jaiswal, Scaffold-based spheroid models of glioblastoma multiforme and its use in drug screening. Biotechnol. Bioeng. 120(8), 2117\u20132132 (2023)","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"773_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41418-020-00679-7","volume":"28","author":"A Mariappan","year":"2021","unstructured":"A. Mariappan, G. Goranci-Buzhala, L. Ricci-Vitiani, R. Pallini, J. Gopalakrishnan, Trends and challenges in modeling glioma using 3D human brain organoids. Cell Death Differ. 28(1), 15\u201323 (2021)","journal-title":"Cell Death Differ."},{"issue":"2","key":"773_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tcb.2019.11.004","volume":"30","author":"RM Marton","year":"2020","unstructured":"R.M. Marton, S.P. Pa\u0219ca, Organoid and assembloid technologies for investigating cellular crosstalk in human brain development and disease. Trends Cell Biol. 30(2), 133\u2013143 (2020)","journal-title":"Trends Cell Biol."},{"issue":"8","key":"773_CR67","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/stem.3368","volume":"39","author":"TK Matsui","year":"2021","unstructured":"T.K. Matsui, Y. Tsuru, K. Hasegawa, K.-i Kuwako, Vascularization of human brain organoids. Stem Cells 39(8), 1017\u20131024 (2021)","journal-title":"Stem Cells"},{"issue":"2","key":"773_CR68","doi-asserted-by":"publisher","first-page":"Fso190","DOI":"10.4155\/fsoa-2017-0003","volume":"3","author":"TG Meijer","year":"2017","unstructured":"T.G. Meijer, K.A. Naipal, A. Jager, van D.C. Gent, Ex vivo tumor culture systems for functional drug testing and therapy response prediction. Future Sci. OA 3(2), Fso190 (2017)","journal-title":"Future Sci. OA"},{"issue":"2","key":"773_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/neuonc\/noaa259","volume":"23","author":"K Mitchell","year":"2021","unstructured":"K. Mitchell, K. Troike, D.J. Silver, J.D. Lathia, The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions. Neuro Oncol. 23(2), 199\u2013213 (2021)","journal-title":"Neuro Oncol."},{"key":"773_CR70","doi-asserted-by":"crossref","unstructured":"A. Mosteiro, L. Pedrosa, A. Ferr\u00e9s, D. Diao, \u00c0. Sierra, J.J. Gonz\u00e1lez, The vascular microenvironment in glioblastoma: a comprehensive review. Biomedicines. 10(6), 1285 (2022)","DOI":"10.3390\/biomedicines10061285"},{"issue":"4","key":"773_CR71","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"C. Neftel, J. Laffy, M.G. Filbin, T. Hara, M.E. Shore, G.J. Rahme et al., An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 178(4), 835\u201349e21 (2019)","journal-title":"Cell"},{"issue":"34","key":"773_CR72","doi-asserted-by":"publisher","first-page":"eabi9119","DOI":"10.1126\/sciadv.abi9119","volume":"7","author":"L Neufeld","year":"2021","unstructured":"L. Neufeld, E. Yeini, N. Reisman, Y. Shtilerman, D. Ben-Shushan, S. Pozzi et al., Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Sci. Adv. 7(34), eabi9119 (2021)","journal-title":"Sci. Adv."},{"key":"773_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100779","volume":"4","author":"PN Nwokoye","year":"2024","unstructured":"P.N. Nwokoye, O.J. Abilez, Bioengineering methods for vascularizing organoids. Cell Rep. Methods 4, 100779 (2024)","journal-title":"Cell Rep. Methods"},{"key":"773_CR74","unstructured":"G. Nzou, The Development of a Multicellular Three-Dimensional Neurovascular Unit Model for Studying Blood-Brain Barrier Integrity in Disease Pathologies: Wake Forest University (2019)"},{"issue":"3","key":"773_CR75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/intbio\/zyaa005","volume":"12","author":"BB O\u2019Connor","year":"2020","unstructured":"B.B. O\u2019Connor, T. Grevesse, J.F. Zimmerman, H.A.M. Ardo\u00f1a, J.A. Jimenez, D. Bitounis et al., Human brain microvascular endothelial cell pairs model tissue-level blood-brain barrier function. Integr. Biol. 12(3), 64\u201379 (2020)","journal-title":"Integr. Biol."},{"issue":"4","key":"773_CR76","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","volume":"23","author":"J Ogawa","year":"2018","unstructured":"J. Ogawa, G.M. Pao, M.N. Shokhirev, I.M. Verma, Glioblastoma model using human cerebral organoids. Cell Rep. 23(4), 1220\u20131229 (2018)","journal-title":"Cell Rep."},{"issue":"1","key":"773_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13287-024-04022-6","volume":"15","author":"L Oliver","year":"2024","unstructured":"L. Oliver, Y. Landais, C. Gratas, P.F. Cartron, F. Paris, D. Heymann et al., Transcriptional landscape of the interaction of human mesenchymal stem cells with glioblastoma in bioprinted co-cultures. Stem Cell Res. Ther. 15(1), 424 (2024)","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"773_CR78","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.stem.2024.09.017","volume":"31","author":"MM Onesto","year":"2024","unstructured":"M.M. Onesto, J.- Kim, S.P. Pasca, Assembloid models of cell-cell interaction to study tissue and disease biology. Cell. Stem Cell 31(11), 1563\u20131573 (2024)","journal-title":"Cell. Stem Cell"},{"issue":"2","key":"773_CR79","doi-asserted-by":"publisher","first-page":"100534","DOI":"10.1016\/j.xpro.2021.100534","volume":"2","author":"A Oudin","year":"2021","unstructured":"A. Oudin, V. Baus, V. Barthelemy, C. Fabian, E. Klein, M. Dieterle et al., Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protoc. 2(2), 100534 (2021)","journal-title":"STAR Protoc."},{"issue":"5","key":"773_CR80","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1021\/acsbiomaterials.3c01569","volume":"10","author":"II Ozbek","year":"2024","unstructured":"I.I. Ozbek, H. Saybasili, K.O. Ulgen, Applications of 3D bioprinting technology to brain cells and brain tumor models: special emphasis to glioblastoma. ACS Biomater. Sci. Eng. 10(5), 2616\u20132635 (2024)","journal-title":"ACS Biomater. Sci. Eng."},{"key":"773_CR81","doi-asserted-by":"publisher","first-page":"823412","DOI":"10.3389\/fddev.2022.823412","volume":"2","author":"C Pacheco","year":"2022","unstructured":"C. Pacheco, C. Martins, J. Monteiro, F. Baltazar, B.M. Costa, B. Sarmento, Glioblastoma vasculature: from its critical role in tumor survival to relevant in vitro modelling. Front. Drug Deliv. 2, 823412 (2022)","journal-title":"Front. Drug Deliv."},{"issue":"1","key":"773_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01077-3","volume":"8","author":"M-D Papaioannou","year":"2020","unstructured":"M.-D. Papaioannou, K. Sangster, R.S. Sajid, U. Djuric, P. Diamandis, Cerebral organoids: emerging ex vivo humanoid models of glioblastoma. Acta Neuropathol. Commun. 8(1), 209 (2020)","journal-title":"Acta Neuropathol. Commun."},{"key":"773_CR83","doi-asserted-by":"crossref","unstructured":"R. Park, Y. Peng, A.R. Yslas, E. Lee, Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model. APL Bioeng. 9(2), 026126 (2025)","DOI":"10.1063\/5.0261875"},{"key":"773_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122864","volume":"314","author":"G Pavlou","year":"2025","unstructured":"G. Pavlou, S. Spitz, F.M. Pramotton, A. Tsai, B.M. Li, X. Wang et al., Engineered 3d human neurovascular model of Alzheimer\u2019s disease to study vascular dysfunction. Biomaterials 314, 122864 (2025)","journal-title":"Biomaterials"},{"key":"773_CR85","doi-asserted-by":"crossref","unstructured":"T. Peng, X. Ma, W. Hua, C. Wang, Y. Chu, M. Sun et al., Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. Cell. Stem Cell. 32(4), 652\u2013669 (2025)","DOI":"10.1016\/j.stem.2025.01.002"},{"issue":"10","key":"773_CR86","doi-asserted-by":"publisher","first-page":"e31402","DOI":"10.1016\/j.heliyon.2024.e31402","volume":"10","author":"RR Raju","year":"2024","unstructured":"R.R. Raju, N.M. AlSawaftah, G.A. Husseini, Modeling of brain tumors using in vitro, in vivo, and microfluidic models: a review of the current developments. Heliyon 10(10), e31402 (2024)","journal-title":"Heliyon"},{"issue":"3","key":"773_CR87","doi-asserted-by":"publisher","first-page":"364","DOI":"10.18063\/ijb.v7i3.364","volume":"7","author":"Y Ren","year":"2021","unstructured":"Y. Ren, X. Yang, Z. Ma, X. Sun, Y. Zhang, W. Li et al., Developments and opportunities for 3D bioprinted organoids. Int. J. Bioprint. 7(3), 364 (2021)","journal-title":"Int. J. Bioprint"},{"issue":"9","key":"773_CR88","doi-asserted-by":"publisher","first-page":"e30637","DOI":"10.1002\/jcb.30637","volume":"125","author":"JH Ribeiro","year":"2024","unstructured":"J.H. Ribeiro, N.J. Villarinho, P.V. Fernandes, T. Spohr, G.P.F. Lopes, Conditioned medium from reactive astrocytes inhibits proliferation, resistance, and migration of p53-mutant glioblastoma spheroid through GLI-1 downregulation. J. Cell. Biochem. 125(9), e30637 (2024)","journal-title":"J. Cell. Biochem."},{"key":"773_CR89","doi-asserted-by":"crossref","unstructured":"N.C. Riedel, de F.W. Faria, A. Alfert, J.M. Bruder, K. Kerl, Three-Dimensional cell culture systems in pediatric and adult brain tumor precision medicine, Cancers. 14, 5972 (2022)","DOI":"10.3390\/cancers14235972"},{"key":"773_CR90","doi-asserted-by":"publisher","first-page":"558381","DOI":"10.3389\/fncel.2020.558381","volume":"14","author":"H Ruiz-Garcia","year":"2020","unstructured":"H. Ruiz-Garcia, K. Alvarado-Estrada, P. Schiapparelli, A. Quinones-Hinojosa, D.M. Trifiletti, Engineering three-dimensional tumor models to study glioma cancer stem cells and tumor microenvironment. Front. Cell. Neurosci. 14, 558381 (2020)","journal-title":"Front. Cell. Neurosci."},{"key":"773_CR91","doi-asserted-by":"crossref","unstructured":"M.J. Rybin, M.E. Ivan, N.G. Ayad, Z. Zeier, Organoid models of glioblastoma and their role in drug discovery. Front. Cell. Neurosci. 15, 605255\u00a0(2021)","DOI":"10.3389\/fncel.2021.605255"},{"issue":"14","key":"773_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203143","volume":"12","author":"G Safarians","year":"2023","unstructured":"G. Safarians, A. Sohrabi, I. Solomon, W. Xiao, S. Bastola, B.W. Rajput et al., Glioblastoma spheroid invasion through soft, brain-like matrices depends on hyaluronic acid-CD44 interactions. Adv. Healthc. Mater. 12(14), e2203143 (2023)","journal-title":"Adv. Healthc. Mater."},{"key":"773_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10743","volume":"7","author":"I Sancho-Martinez","year":"2016","unstructured":"I. Sancho-Martinez, E. Nivet, Y. Xia, T. Hishida, A. Aguirre, A. Ocampo et al., Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat. Commun. 7, 10743 (2016)","journal-title":"Nat. Commun."},{"key":"773_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcdb.2022.10.001","volume":"144","author":"G Saorin","year":"2023","unstructured":"G. Saorin, I. Caligiuri, F. Rizzolio, Microfluidic organoids-on-a-chip: the future of human models. Semin. Cell Dev. Biol. 144, 41\u201354 (2023)","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"773_CR95","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1039\/D3LC00930K","volume":"24","author":"M Shaji","year":"2024","unstructured":"M. Shaji, A. Tamada, K. Fujimoto, K. Muguruma, S.L. Karsten, R. Yokokawa, Deciphering potential vascularization factors of on-chip co-cultured hiPSC-derived cerebral organoids. Lab Chip 24(4), 680\u2013696 (2024)","journal-title":"Lab Chip"},{"issue":"1","key":"773_CR96","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"P. Sharma, A. Aaroe, J. Liang, V.K. Puduvalli, Tumor microenvironment in glioblastoma: current and emerging concepts. Neuro-Oncology Advances 5(1), vdad009 (2023)","journal-title":"Neuro-Oncology Advances"},{"key":"773_CR97","doi-asserted-by":"publisher","first-page":"1488691","DOI":"10.3389\/fncel.2024.1488691","volume":"18","author":"MBC Sim\u00f5es-Abade","year":"2024","unstructured":"M.B.C. Sim\u00f5es-Abade, M. Patterer, A.M. Nicaise, S. Pluchino, Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis. Front. Cell. Neurosci. 18, 1488691 (2024)","journal-title":"Front. Cell. Neurosci."},{"key":"773_CR98","doi-asserted-by":"crossref","unstructured":"A. Sinha, M. Maibam, R. Jain, K. Aggarwal, A.K. Sahu, P. Gupta et al., Organoid: biomedical application, biobanking, and pathways to translation. Heliyon. 11(10), e43028 (2025)","DOI":"10.1016\/j.heliyon.2025.e43028"},{"issue":"8","key":"773_CR99","first-page":"1962","volume":"63","author":"Y Sonoda","year":"2003","unstructured":"Y. Sonoda, M. Kanamori, D.F. Deen, S.Y. Cheng, M.S. Berger, R.O. Pieper, Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis. Cancer Res. 63(8), 1962\u20131968 (2003)","journal-title":"Cancer Res."},{"issue":"1","key":"773_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41277-z","volume":"9","author":"BW Stringer","year":"2019","unstructured":"B.W. Stringer, B.W. Day, R.C. D\u2019Souza, P.R. Jamieson, K.S. Ensbey, Z.C. Bruce et al., A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. Sci. Rep. 9(1), 4902 (2019)","journal-title":"Sci. Rep."},{"issue":"1","key":"773_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-022-00775-w","volume":"12","author":"E Suarez-Martinez","year":"2022","unstructured":"E. Suarez-Martinez, I. Suazo-Sanchez, M. Celis-Romero, A. Carnero, 3D and organoid culture in research: physiology, hereditary genetic diseases and cancer. Cell. Biosci. 12(1), 39 (2022)","journal-title":"Cell. Biosci."},{"issue":"7","key":"773_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2025.102534","volume":"20","author":"Y Sun","year":"2025","unstructured":"Y. Sun, X. Wang, Z. Zhang, K.H. Park, Y. Wu, W. Dong et al., Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture model. Stem Cell Reports 20(7), 102534 (2025)","journal-title":"Stem Cell Reports"},{"key":"773_CR103","doi-asserted-by":"publisher","first-page":"e76707","DOI":"10.7554\/eLife.76707","volume":"11","author":"X-Y Sun","year":"2022","unstructured":"X.-Y. Sun, X.-C. Ju, Y. Li, P.-M. Zeng, J. Wu, Y.-Y. Zhou et al., Generation of vascularized brain organoids to study neurovascular interactions. Elife. 11, e76707 (2022)","journal-title":"Elife"},{"issue":"2","key":"773_CR104","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13365-023-01133-3","volume":"29","author":"M Swingler","year":"2023","unstructured":"M. Swingler, M. Donadoni, A. Bellizzi, S. Cakir, I.K. Sariyer, iPSC-derived three-dimensional brain organoid models and neurotropic viral infections. J. Neurovirol. 29(2), 121\u2013134 (2023)","journal-title":"J. Neurovirol."},{"issue":"5","key":"773_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004776","volume":"33","author":"M Tang","year":"2021","unstructured":"M. Tang, J.N. Rich, S. Chen, Biomaterials and 3D bioprinting strategies to model glioblastoma and the blood\u2013brain barrier. Adv. Mater. 33(5), 2004776 (2021)","journal-title":"Adv. Mater."},{"issue":"1","key":"773_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98911-y","volume":"11","author":"AS Tatla","year":"2021","unstructured":"A.S. Tatla, A.W. Justin, C. Watts, A.E. Markaki, A vascularized tumoroid model for human glioblastoma angiogenesis. Sci. Rep. 11(1), 19550 (2021)","journal-title":"Sci. Rep."},{"issue":"1","key":"773_CR107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-023-03821-2","volume":"394","author":"P Teli","year":"2023","unstructured":"P. Teli, V. Kale, A. Vaidya, Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting. Cell. Tissue Res. 394(1), 75\u201391 (2023)","journal-title":"Cell. Tissue Res."},{"key":"773_CR108","doi-asserted-by":"crossref","unstructured":"E. Testa, C. Palazzo, R. Mastrantonio, M.T. Viscomi, Dynamic interactions between tumor cells and brain microvascular endothelial cells in glioblastoma. Cancers (Basel). 14(13), 3128 (2022)","DOI":"10.3390\/cancers14133128"},{"issue":"1","key":"773_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-022-00332-z","volume":"26","author":"M Tran","year":"2022","unstructured":"M. Tran, C. Heo, L.P. Lee, H. Cho, Human mini-blood\u2013brain barrier models for biomedical neuroscience research: a review. Biomater. Res. 26(1), 82 (2022)","journal-title":"Biomater. Res."},{"issue":"15","key":"773_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302831","volume":"13","author":"Y-T Tung","year":"2024","unstructured":"Y.-T. Tung, Y.-C. Chen, K. Derr, K. Wilson, M.J. Song, M. Ferrer, A 3d bioprinted human neurovascular unit model of glioblastoma tumor growth. Adv. Healthc. Mater. 13(15), 2302831 (2024)","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"773_CR111","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.7150\/thno.69682","volume":"12","author":"DH Upton","year":"2022","unstructured":"D.H. Upton, C. Ung, S.M. George, M. Tsoli, M. Kavallaris, D.S. Ziegler, Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics. 12(10), 4734\u20134752 (2022)","journal-title":"Theranostics"},{"key":"773_CR112","doi-asserted-by":"publisher","first-page":"1419526","DOI":"10.3389\/fncel.2024.1419526","volume":"18","author":"N Urrestizala-Arenaza","year":"2024","unstructured":"N. Urrestizala-Arenaza, S. Cerchio, F. Cavaliere, C. Magliaro, Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive. Front. Cell. Neurosci. 18, 1419526 (2024)","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"773_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300197","volume":"6","author":"M Vaezzadeh","year":"2023","unstructured":"M. Vaezzadeh, E. Kachooei, S. Krishnamurthy, P. Manandhar, A. Nadort, G.J. Guillemin et al., Combination drug therapy of glioblastoma: lessons from 3D in vitro models and the roadmap for future research. Adv. Ther. 6(11), 2300197 (2023)","journal-title":"Adv. Ther."},{"issue":"1","key":"773_CR114","first-page":"vdad152","volume":"5","author":"M Verduin","year":"2023","unstructured":"M. Verduin, L. Hoosemans, M. Vanmechelen, van M. Heumen, J.A.F. Piepers, G. Astuti et al., Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neurooncol Adv. 5(1), vdad152 (2023)","journal-title":"Neurooncol Adv."},{"issue":"11","key":"773_CR115","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1007\/s12035-022-02996-z","volume":"59","author":"A Virtuoso","year":"2022","unstructured":"A. Virtuoso, De C. Luca, G. Cirillo, M. Riva, G. Romano, A. Bentivegna et al., Tumor microenvironment and immune escape in the time course of glioblastoma. Mol. Neurobiol. 59(11), 6857\u20136873 (2022)","journal-title":"Mol. Neurobiol."},{"issue":"5\u20136","key":"773_CR116","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/ten.tea.2020.0110","volume":"27","author":"C Wang","year":"2021","unstructured":"C. Wang, S. Sinha, X. Jiang, L. Murphy, S. Fitch, C. Wilson et al., Matrix stiffness modulates patient-derived glioblastoma cell fates in three-dimensional hydrogels. Tissue Eng. Part A 27(5\u20136), 390\u2013401 (2021)","journal-title":"Tissue Eng. Part A"},{"issue":"1","key":"773_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00500-5","volume":"8","author":"C Wang","year":"2024","unstructured":"C. Wang, M. Sun, C. Shao, L. Schlicker, Y. Zhuo, Y. Harim et al., A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs. NPJ Precis. Oncol. 8(1), 19 (2024)","journal-title":"NPJ Precis. Oncol."},{"key":"773_CR118","doi-asserted-by":"crossref","unstructured":"X. Wang, Y. Sun, D.Y. Zhang, G.- Ming, H. Song, Glioblastoma modeling with 3D organoids: progress and challenges. Oxf. Open Neurosci. 2, kvad008(2023).","DOI":"10.1093\/oons\/kvad008"},{"key":"773_CR119","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biomaterials.2019.02.024","volume":"202","author":"C Wang","year":"2019","unstructured":"C. Wang, J. Li, S. Sinha, A. Peterson, G.A. Grant, F. Yang, Mimicking brain tumor-vasculature microanatomical architecture via co-culture of brain tumor and endothelial cells in 3D hydrogels. Biomaterials. 202, 35\u201344 (2019)","journal-title":"Biomaterials"},{"issue":"9","key":"773_CR120","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41591-021-01443-1","volume":"27","author":"L Wang","year":"2021","unstructured":"L. Wang, D. Sievert, A.E. Clark, S. Lee, H. Federman, B.D. Gastfriend et al., A human three-dimensional neural-perivascular \u2018assembloid\u2019 promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology. Nat. Med. 27(9), 1600\u20131606 (2021)","journal-title":"Nat. Med."},{"issue":"4","key":"773_CR121","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/organoids2040019","volume":"2","author":"X Wang","year":"2023","unstructured":"X. Wang, B.M. Bijonowski, N.A. Kurniawan, Vascularizing organoids to promote long-term organogenesis on a chip. Organoids 2(4), 239\u2013255 (2023)","journal-title":"Organoids"},{"issue":"2","key":"773_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103426","volume":"28","author":"J Wanigasekara","year":"2023","unstructured":"J. Wanigasekara, P.J. Cullen, P. Bourke, B. Tiwari, J.F. Curtin, Advances in 3D culture systems for therapeutic discovery and development in brain cancer. Drug Discov. Today 28(2), 103426 (2023)","journal-title":"Drug Discov. Today"},{"issue":"2","key":"773_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276248","volume":"18","author":"J Wanigasekara","year":"2023","unstructured":"J. Wanigasekara, L.J. Carroll, P.J. Cullen, B. Tiwari, J.F. Curtin, Three-dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research. PLoS One 18(2), e0276248 (2023)","journal-title":"PLoS One"},{"issue":"10","key":"773_CR124","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1111\/cns.14272","volume":"29","author":"J Wen","year":"2023","unstructured":"J. Wen, F. Liu, Q. Cheng, N. Weygant, X. Liang, F. Fan et al., Applications of organoid technology to brain tumors. CNS Neurosci. Ther. 29(10), 2725\u20132743 (2023)","journal-title":"CNS Neurosci. Ther."},{"key":"773_CR125","doi-asserted-by":"publisher","first-page":"118529","DOI":"10.1016\/j.atherosclerosis.2024.118529","volume":"398","author":"N Werschler","year":"2024","unstructured":"N. Werschler, C. Quintard, S. Nguyen, J. Penninger, Engineering next generation vascularized organoids. Atherosclerosis. 398, 118529 (2024)","journal-title":"Atherosclerosis"},{"issue":"1","key":"773_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52204-7","volume":"9","author":"P W\u00f6rsd\u00f6rfer","year":"2019","unstructured":"P. W\u00f6rsd\u00f6rfer, N. Dalda, A. Kern, S. Kr\u00fcger, N. Wagner, C.K. Kwok et al., Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Sci. Rep. 9(1), 15663 (2019)","journal-title":"Sci. Rep."},{"key":"773_CR127","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1111\/jcmm.16578","volume":"25","author":"T Xia","year":"2021","unstructured":"T. Xia, W.L. Du, X.Y. Chen, Y.N. Zhang, Organoid models of the tumor microenvironment and their applications. J. Cell. Mol. Med. 25, 5829\u20135841 (2021)","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"773_CR128","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1158\/0008-5472.CAN-17-2429","volume":"78","author":"W Xiao","year":"2018","unstructured":"W. Xiao, R. Zhang, A. Sohrabi, A. Ehsanipour, S. Sun, J. Liang et al., Brain-mimetic 3d culture platforms allow investigation of cooperative effects of extracellular matrix features on therapeutic resistance in glioblastoma. Cancer Res. 78(5), 1358\u20131370 (2018)","journal-title":"Cancer Res."},{"key":"773_CR129","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12964-021-00777-0","volume":"19","author":"X Xu","year":"2021","unstructured":"X. Xu, L. Li, L. Luo, L. Shu, X. Si, Z. Chen et al., Opportunities and challenges of glioma organoids. Cell Commun. Signal. 19, 102 (2021)","journal-title":"Cell Commun. Signal."},{"key":"773_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.735","volume":"5","author":"Q Yao","year":"2024","unstructured":"Q. Yao, S. Cheng, Q. Pan, J. Yu, G. Cao, L. Li et al., Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm 5, e735 (2024)","journal-title":"MedComm"},{"issue":"14","key":"773_CR131","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.3390\/cancers15143622","volume":"15","author":"IA Yasmin","year":"2023","unstructured":"I.A. Yasmin, A. Dharmarajan, S. Warrier, iPSC-derived glioblastoma cells have enhanced stemness Wnt\/\u03b2-catenin activity which is negatively regulated by Wnt antagonist sFRP4. Cancers 15(14), 3622 (2023)","journal-title":"Cancers"},{"issue":"7","key":"773_CR132","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41551-019-0363-x","volume":"3","author":"HG Yi","year":"2019","unstructured":"H.G. Yi, Y.H. Jeong, Y. Kim, Y.J. Choi, H.E. Moon, S.H. Park et al., A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat. Biomed. Eng. 3(7), 509\u2013519 (2019)","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"773_CR133","doi-asserted-by":"publisher","DOI":"10.1088\/2516-1091\/ac7833","volume":"4","author":"D Yigci","year":"2022","unstructured":"D. Yigci, M.R. Sarabi, M. Ustun, N. Atceken, E. Sokullu, T. Bagci-Onder et al., 3D bioprinted glioma models. Prog. Biomed. Eng. 4(4), 042001 (2022)","journal-title":"Prog. Biomed. Eng."},{"key":"773_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102063","volume":"49","author":"M Zhang","year":"2020","unstructured":"M. Zhang, J.J. Vandana, L. Lacko, S. Chen, Modeling cancer progression using human pluripotent stem cell-derived cells and organoids. Stem Cell Res. 49, 102063 (2020)","journal-title":"Stem Cell Res."},{"issue":"4","key":"773_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7081","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Y. Zhang, Y. Shao, Y. Li, X. Li, X. Zhang, The generation of glioma organoids and the comparison of two culture methods. Cancer Med. 13(4), e7081 (2024)","journal-title":"Cancer Med."},{"issue":"3","key":"773_CR136","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1039\/D0LC01186J","volume":"21","author":"S Zhang","year":"2021","unstructured":"S. Zhang, Z. Wan, R.D. Kamm, Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature. Lab Chip 21(3), 473\u2013488 (2021)","journal-title":"Lab Chip"},{"key":"773_CR137","doi-asserted-by":"crossref","unstructured":"X. Zhao, Z. Xu, L. Xiao, T. Shi, H. Xiao, Y. Wang et al., Review on the vascularization of organoids and organoids-on-a-Chip. Front. Bioeng. Biotechnol. 9\u00a0(2021)","DOI":"10.3389\/fbioe.2021.637048"},{"key":"773_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.147937","volume":"1788","author":"Y Zhao","year":"2022","unstructured":"Y. Zhao, L. Gan, L. Ren, Y. Lin, C. Ma, X. Lin, Factors influencing the blood-brain barrier permeability. Brain Res. 1788, 147937 (2022)","journal-title":"Brain Res."},{"issue":"9","key":"773_CR139","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Y. Zhao, M. Shen, L. Wu, H. Yang, Y. Yao, Q. Yang et al., Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 14(9), 587 (2023)","journal-title":"Cell Death Dis."},{"key":"773_CR140","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/organoids1020012","volume":"1","author":"Y Zhu","year":"2022","unstructured":"Y. Zhu, E. Kang, M. Wilson, T. Basso, E. Chen, Y. Yu et al., 3D tumor spheroid and organoid to model tumor microenvironment for cancer immunotherapy. Organoids 1, 149\u2013167 (2022)","journal-title":"Organoids"},{"issue":"4","key":"773_CR141","doi-asserted-by":"publisher","first-page":"444","DOI":"10.18063\/ijb.v7i4.444","volume":"7","author":"P Zhuang","year":"2021","unstructured":"P. Zhuang, Y.H. Chiang, M.S. Fernanda, M. He, Using spheroids as building blocks towards 3D bioprinting of tumor microenvironment. Int. J. Bioprint. 7(4), 444 (2021)","journal-title":"Int. J. Bioprint."}],"container-title":["Biomedical Microdevices"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10544-025-00773-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10544-025-00773-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10544-025-00773-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T02:03:04Z","timestamp":1768356184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10544-025-00773-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s10544-025-00773-y","relation":{},"ISSN":["1387-2176","1572-8781"],"issn-type":[{"value":"1387-2176","type":"print"},{"value":"1572-8781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"26 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"46"}}